BCRX BioCryst Pharmaceuticals, Inc.
$8.10▲ +2.79%
Healthcare
Other
Volume 8.71M
Avg Volume (10D) 5.28M
Key Metrics & Fundamentals
Market Cap
$2.07B
P/E Ratio
–
Div Yield
0.00%
52W Range
6.23 - 11.22
% vs 50 MA
-7.04%
% vs 200 MA
-7.15%
RSI-14
47.5
MACD Histogram
+0.0200
Beta (1Y vs SPY)
0.65
Free Cash Flow
$104.13M
Gross Rev
$218.25M
Gross Profit
$214.41M
EBITDA
$101.67M
COGS
$3.84M
Operating Exp
$115.95M
Operating Income
$98.47M
EBIT
$98.47M
Pretax Income
$79.47M
Net Income
$78.40M
EPS (Diluted)
0.30
Price & Volume History
Loading chart…
Recent News
BioCryst to Report Third Quarter 2026 Financial Results on November 4
GlobeNewswire · Oct 21, 2026 4:01 PM ET
BioCryst Pharmaceuticals Pellet Form of Hereditary Angioedema Treatment Approved by US FDA
MT Newswires · Oct 21, 2026 8:48 AM ET
BioCryst Announces U.S. FDA Approval of ORLADEYO® 150 mg Oral Pellets for Adults and Adolescents with HAE
GlobeNewswire · Oct 21, 2026 7:00 AM ET
Wedbush Cuts Price Target on BioCryst Pharmaceuticals to $18 From $20, Keeps Outperform Rating
MT Newswires · Oct 19, 2026 7:11 AM ET
BioCryst (BCRX) Trades at Just 11x Forward Earnings. Is the Market Pricing In Trouble?
Insider Monkey · Oct 15, 2026 2:05 PM ET
BioCryst Pharmaceuticals Forms Scientific Advisory Board as R&D Model Evolves
MT Newswires · Oct 5, 2026 8:33 AM ET
BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth
GlobeNewswire · Oct 5, 2026 7:00 AM ET
Claude AI Just Bought These 2 Pharma Stocks
Insider Monkey · Sep 29, 2026 9:26 AM ET
Is BioCryst’s (BCRX) Newest Approval Bigger Than It Looks?
Insider Monkey · Sep 23, 2026 6:26 AM ET
Biopharma Stock With Layers of Technical Support in Place
Schaeffer's Investment Research · Sep 21, 2026 2:44 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BCRX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.